Topics

Ncardia Company Profile

10:49 EST 27th January 2020 | BioPortfolio

Ncardia (www.ncardia.com) believes that stem cell technology will help to get better medicines to patients faster. The company develops, produces and commercializes highly predictive human cellular assay systems for safety and efficacy testing. The cardiac product portfolio encompasses a broad panel of hiPSC derived Cardiomyocytes (Pluricyte®, Cor.4U® and vCor.4U®) as well cardiac fibroblasts (FibroCor.4U®). In addition, the company delivers the CardioplateTM product line of quality controlled ready to use assay plates. The neural cell portfolio contains the pan-neuronal product CNS4U, the peripheral neurons product Peri.4U®, and astrocyte product Astro.4U®.


News Articles [8 Associated News Articles listed on BioPortfolio]

Ncardia and BlueRock Form Collaboration

Agreement and licensing of process development technologies for the manufacture of iPSC-derived cardiomyocytes.

Ncardia and BlueRock Therapeutics Announce Collaboration

Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes.

Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes

Ncardia and BlueRock Therapeutics today announced an agreement covering process development technologies for the manufacture of induced pluripotent stem cell (iPSC)-derived cardiomyocytes. Under the ...

Evotec: Erweiterung der Entwicklungsplattform durch Experten-Akquise

Weiter positive News produziert der Wirkstoffhersteller Evotec. Wie das Unternehmen heute bekannt gibt, wird die iPSC-Plattfor weiter ausgebaut. Dazu wurde von der Ncardia AG neben dem geistigen Ei...

Evotec kauft geistiges Eigentum

Evotec SE baut seine Wirkstoffforschungs-Plattform iPSC weiter aus. Zu diesem Zweck hat Evotec von dem auf Stammzellen spezialisierten Unternehmen Ncardia AG geistiges Eigentum für iPSC-basierte ph.....

Evotec baut Stammzellforschung durch Zukauf aus - Aktie steigt

HAMBURG (dpa-AFX) - Das Biotech-Unternehmen Evotec baut seine Stammzellforschung durch einen Portfolio-Zukauf von Ncardia aus. Der Konzern habe geistiges Eigentum für die Wirkstoffentwicklung auf ...

Evotec AG: Evotec Expands Its IPSC Discovery Platform

ACQUIRED ASSETS FROM NCARDIA AG INCLUDE IP PORTFOLIO, IPSC-BASED CELLULAR PRODUCTS AND AN EXPERIENCED STEM CELL BIOLOGY TEAM EXPANSION OF IPSC DISCOVERY PLATFORM STRENGTHENS EVOTEC'S POSITION AS A...

BioPharm International® Presents ‘From Small-Scale Stem Cell Production to Large-Scale hiPSC-Based Drug Development: The Flexibility of Stirred-Tank Bioreactors’ Webcast

This webcast explores the benefits of stirred-tank bioreactors in production of food, biofuels and pharmaceutical products BioPharm International®, a digital resource of technical articles, technol...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Ncardia

Ncardia (www.ncardia.com) believes that stem cell technology will help to get better medicines to patients faster. The company develops, produces and commercializes highly ...

More Information about "Ncardia" on BioPortfolio

We have published hundreds of Ncardia news stories on BioPortfolio along with dozens of Ncardia Clinical Trials and PubMed Articles about Ncardia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ncardia Companies in our database. You can also find out about relevant Ncardia Drugs and Medications on this site too.

Quick Search

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...


Corporate Database Quicklinks



Searches Linking to this Company Record